MINIMAL NUMBER OF CIRCULATING CD34-BLOOD PROGENITOR-CELL TRANSPLANTATION( CELLS TO ENSURE SUCCESSFUL LEUKAPHERESIS AND ENGRAFTMENT IN AUTOLOGOUS PERIPHERAL)
Ja. Perezsimon et al., MINIMAL NUMBER OF CIRCULATING CD34-BLOOD PROGENITOR-CELL TRANSPLANTATION( CELLS TO ENSURE SUCCESSFUL LEUKAPHERESIS AND ENGRAFTMENT IN AUTOLOGOUS PERIPHERAL), Transfusion, 38(4), 1998, pp. 385-391
BACKGROUND: The number of peripheral blood (PB) CD34+ cells has been w
idely used to monitor the timing of leukapheresis for autologous trans
plantation. However, no cutoff value for CD34+ cells in PB has been de
fined as a guideline for the identification of patients in whom the ha
rvest would be effective and those in whom there was a high probabilit
y of failure. STUDY DESIGN AND METHODS: The present study investigated
the best threshold of CD34+ cells in PB for successful harvesting and
engraftment, using 263 PB samples with their corresponding leukaphere
sis components. In addition, that measure has been compared to other c
ommonly used criteria such as the white cell count, the number of mono
nuclear cells, and the number of colony-forming units-granulocyte macr
ophage in PB. RESULTS: Time to engraftment of both granulocytes and pl
atelets was significantly influenced by the number of CD34+ cells tran
sfused, but all patients receiving greater than or equal to 0.75 x 10(
6) CD34+ cells per kg achieved engraftment within a reasonable number
of days (>0.5 x 10(9)/L granulocytes by Day II and 220 x 10(9)/L plate
lets by Day 13). A clear correlation between the number of CD34+ cells
per mu L in PB and of CD34+ cells per kg collected was found at each
apheresis (r = 0.9, p<0.0001). Moreover, the number of CD34+ cells per
mu L measured in PB the day the first leukapheresis was initiated dis
played an excellent correlation with the total amount of CD34+ cells p
er kg finally collected (r = 0.81, p<0.0001). On the basis of the regr
ession curve obtained and the clinical engraftment results, it was fou
nd that the presence of >5 CD34+ cells per mu L in PB ensured a good y
ield from the harvest in 95 percent of patients and would avoid an uns
uccessful harvest in 81 percent of cases. CONCLUSION: A dose of only 0
.75 x 10(6) CD34+ cells per kg guarantees hematopoietic recovery withi
n a reasonable number of days. To initiate a leukapheresis from which
enough progenitor cells may confidently be obtained, a minimum of 5 CD
34+ cells per mu L in PB is required.